GlassScriptPhysician profile
Chainarong Limvarapuss
NPI 1053341784
$60,283.86
in general payments reported to CMS, 2019-2025
94 companies · $4,852 in 2025
The $4,852 reported for 2025 was more than what 82% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,139 · 2021: $4,635 · 2022: $14K · 2023: $8,229 · 2024: $5,772 · 2025: $4,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Consulting Fee: $3,133 · Travel and Lodging: $820 · Education: $188 · Gift: $33.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,679.86 |
| Consulting Fee | $3,133.00 |
| Travel and Lodging | $819.80 |
| Education | $187.57 |
| Gift | $33.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11,701.92 | 2019-2025 | |
| Kite Pharma, INC. | $6,394.43 | 2020-2023 | Yescarta |
| Celgene Corporation | $4,852.62 | 2019-2025 | Reblozyl, Opdivo, Pomalyst |
| Aurobindo Pharma USA, INC. | $3,552.78 | 2019 | |
| Beigene USA, INC. | $3,284.03 | 2020-2024 | Brukinsa |
| US Oncology Corporate, INC. | $3,107.57 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,927.62 | 2019-2025 | Imfinzi, Enhertu, Tagrisso |
| Pfizer INC. | $1,758.05 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,533.69 | 2019-2025 | Libtayo |
| Lilly USA, LLC | $1,400.40 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $1,396.71 | 2019-2025 | Darzalex, Rybrevant, Erleada |
| Merck Sharp & Dohme LLC | $1,261.70 | 2019-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $993.67 | 2019-2025 | Opdivo, Opdualag, Augtyro |
| Genentech USA, INC. | $932.55 | 2019-2025 | Venclexta, Phesgo, Polivy |
| Amgen INC. | $914.78 | 2019-2025 | Nplate, Vectibix, Xgeva |
Show all 92 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $902.51 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Eisai INC. | $846.35 | 2019-2025 | |
| Genzyme Corporation | $827.21 | 2019-2025 | |
| Daiichi Sankyo INC. | $814.69 | 2020-2025 | Enhertu, Injectafer, Datroway |
| Mckesson Specialty Care Distribution, LLC | $811.59 | 2019-2020 | |
| Seagen INC. | $727.12 | 2019-2023 | Tukysa, Padcev, Adcetris |
| Takeda Pharmaceuticals U.S.A., INC. | $672.84 | 2019-2025 | Fruzaqla, Ninlaro, Iclusig |
| Karyopharm Therapeutics INC. | $643.94 | 2023-2025 | Xpovio |
| Gilead Sciences, INC. | $576.79 | 2019-2025 | Trodelvy |
| Alexion Pharmaceuticals, INC. | $550.40 | 2019-2025 | Ultomiris |
| Pharmacyclics LLC, An Abbvie Company | $507.96 | 2019-2023 | Imbruvica |
| Incyte Corporation | $491.12 | 2019-2025 | Monjuvi, Jakafi, Pemazyre |
| Astellas Pharma US INC | $454.05 | 2019-2023 | Padcev |
| Array Biopharma INC | $378.79 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Jazz Pharmaceuticals INC. | $344.22 | 2020-2025 | |
| Rigel Pharmaceuticals, INC. | $292.78 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Pharmaessentia USA Corporation | $230.07 | 2023-2025 | Besremi |
| Sobi, INC | $220.26 | 2022-2024 | |
| Clovis Oncology, INC. | $219.17 | 2019-2021 | |
| Stemline Therapeutics INC. | $208.18 | 2020-2025 | Orserdu |
| Organon LLC | $207.29 | 2021-2025 | Ontruzant |
| Abbvie INC. | $177.79 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $172.76 | 2021-2025 | Onivyde |
| Mirati Therapeutics, INC. | $172.48 | 2023-2024 | Krazati |
| Servier Pharmaceuticals LLC | $166.52 | 2021-2025 | |
| Exelixis INC. | $162.23 | 2019-2025 | Cabometyx |
| Taiho Oncology, INC. | $159.44 | 2019-2024 | |
| Emd Serono, INC. | $159.20 | 2021-2024 | |
| Myovant Sciences INC. | $157.51 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $148.78 | 2022-2025 | Fotivda |
| Acrotech Biopharma INC. | $125.82 | 2021-2022 | |
| Novocure INC. | $125.72 | 2025 | Optune Lua (Novottf-200t), Optune Gio |
| Emmaus Medical, INC. | $125.64 | 2022-2023 | Endari |
| Myriad Genetic Laboratories, INC. | $124.30 | 2021-2025 | Precisetumor |
| Dendreon Pharmaceuticals LLC | $122.04 | 2019-2023 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $117.51 | 2019-2025 | |
| Blueprint Medicines Corporation | $116.98 | 2022-2023 | Ayvakit |
| Apellis Pharmaceuticals, INC. | $115.70 | 2023-2024 | Empaveli |
| Springworks Therapeutics, INC. | $115.61 | 2024-2025 | Ogsiveo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.82 | 2019-2021 | |
| Deciphera Pharmaceuticals INC. | $111.19 | 2021-2025 | Qinlock, Romvimza |
| Epizyme, INC. | $102.86 | 2020-2022 | |
| Tesaro, INC. | $97.93 | 2019 | |
| Global Blood Therapeutics, INC. | $83.06 | 2021-2022 | |
| Kyowa Kirin, INC. | $82.21 | 2022-2025 | Poteligeo |
| Adc Therapeutics America, INC. | $78.55 | 2023-2025 | |
| Amag Pharmaceuticals, INC. | $73.11 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $73.08 | 2023-2025 | Orgovyx |
| Agios Pharmaceuticals, INC. | $67.53 | 2019-2024 | |
| Tempus Ai, INC | $64.49 | 2025 | Xt Cdx |
| Tersera Therapeutics LLC | $61.06 | 2019-2025 | Xermelo |
| Spectrum Pharmaceuticals INC. | $57.12 | 2024-2025 | Rolvedon |
| Sanofi-Aventis U.S. LLC | $53.43 | 2021 | |
| Syndax Pharmaceuticals, INC. | $51.92 | 2025 | |
| Acceleron Pharma, INC. | $47.75 | 2021 | |
| Octapharma USA, INC. | $44.31 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $41.89 | 2022-2023 | Givlaari |
| Morphosys, US INC. | $41.10 | 2021-2024 | Monjuvi |
| Heron Therapeutics, INC. | $40.42 | 2019-2021 | |
| Ge Healthcare | $39.31 | 2022 | |
| Roche Diagnostics Corporation | $34.99 | 2021 | |
| Immunocore Limited | $33.49 | 2025 | Kimmtrak |
| Recordati_rare_diseases_inc. | $30.00 | 2025 | Enjaymo |
| Coherus Oncology, INC. | $29.81 | 2024 | |
| Iovance Biotherapeutics, INC. | $25.39 | 2025 | Amtagvi |
| Biocon Biologics INC | $21.84 | 2024 | Ogivri |
| Geron Corporation | $21.69 | 2025 | Rytelo |
| Beone Medicines USA, INC. | $20.80 | 2025 | Brukinsa |
| Legend Biotech USA INC. | $17.91 | 2025 | Carvykti |
| Mylan Institutional INC. | $17.06 | 2021 | |
| Amneal Pharmaceuticals LLC | $16.72 | 2023 | Neupogen, Avastin, Neulasta |
| Azurity Pharmaceuticals, INC. | $16.57 | 2025 | |
| Invivyd INC | $15.67 | 2025 | Pemgarda |
| Genmab U.S., INC. | $14.16 | 2024 | Epkinly |
| Foundation Medicine, INC. | $13.30 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $12.37 | 2022 | |
| Dova Pharmaceuticals | $12.07 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Brukinsa $2,077Libtayo $1,289Enhertu $651Xpovio $644Keytruda $607Opdivo $490Verzenio $454Reblozyl $436Jemperli $416Zejula $416Lenvima $386Jaypirca $307Scemblix $307Xtandi $287Imfinzi $273Mektovi $269Braftovi $269Tukysa $268Darzalex $251Kisqali $251Besremi $230Ibrance $229Lynparza $227Imbruvica $226Lorbrena $224Fabhalta $212Tagrisso $211Talzenna $210Padcev $208Orgovyx $205Venclexta $192Orserdu $185Rybrevant $185Nplate $174Krazati $172Ultomiris $170Inlyta $166Rezlidhia $163Tavalisse $163Trodelvy $163Erleada $159Opdualag $158Monjuvi $157Yescarta $151Sarclisa $148Vectibix $141Epkinly $135Calquence $134Fotivda $132Xgeva $124Phesgo $121Ogsiveo $116Tecvayli $110Welireg $108Doptelet $107Fruzaqla $106Optune Lua (Novottf-200t) $103Ninlaro $101Bosulif $96.90Elrexfio $96.32Polivy $95.59Qinlock $93.20Adcetris $92.38Ontruzant $87.47Lumakras $86.73Pomalyst $81.72Tibsovo $80.31Ojjaara $77.42Iclusig $77.30Cabometyx $75.56Talvey $67.57Tasigna $65.58Comirnaty $65.33Xt Cdx $64.49Carvykti $63.07Keytruda Qlex $60.96Injectafer $58.79Oxbryta $58.06Datroway $57.19Rolvedon $57.12Onivyde $56.61Itovebi $49.12Jevtana $48.93Ayvakit $48.50Empaveli $46.56Besponsa $46.06Stivarga $44.70Vitrakvi $44.70Idhifa $42.96Tecentriq $41.78Jakafi $41.65Provenge $40.31Gavreto $40.18Poteligeo $39.98Wayrilz $39.75Precisetumor $37.74Elitek $36.54Ziihera $35.97Piqray $34.77Zepzelca $33.55
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chainarong Limvarapuss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.